Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50–64 years of age

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50–64 years of age
Authors
Keywords
Influenza vaccines, Inactivated, Clinical trial, Phase II, Middle aged, Safety
Journal
VACCINE
Volume 33, Issue 51, Pages 7188-7193
Publisher
Elsevier BV
Online
2015-11-08
DOI
10.1016/j.vaccine.2015.10.131

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.